Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Office of Dr. Avrom Epstein, MD
mi
from
Columbus, OH
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Office of Dr. Avrom Epstein, MD
mi
from
Columbus, OH
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  12/31/1969
Save Sight Institute
mi
from
Sydney,
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 12/31/1969
Save Sight Institute
mi
from
Sydney,
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Associates
mi
from
Birmingham, AL
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Associates
mi
from
Birmingham, AL
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Consultants, Ltd.
mi
from
Phoenix, AZ
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Consultants, Ltd.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
HealthPartners Riverside Clinic
mi
from
Minneapolis, MN
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
HealthPartners Riverside Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
St. Vincent Charity Hospital
mi
from
Cleveland, OH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
St. Vincent Charity Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Cardiology Associates
mi
from
Philadelphia, PA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Cardiology Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Cardiology Consultants of Philadelphia
mi
from
Philadelphia, PA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Cardiology Consultants of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Kelsey Research Foundation
mi
from
Houston, TX
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Kelsey Research Foundation
mi
from
Houston, TX
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Long Beach VA Medical Center
mi
from
Long Beach, CA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Long Beach VA Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Christiana Care Health Services, Inc
mi
from
Newark, DE
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Wake Forest University, Geriatrics
mi
from
Greensboro, NC
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Wake Forest University, Geriatrics
mi
from
Greensboro, NC
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Wake Forest University, Cardiology
mi
from
Winston-Salem, NC
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Wake Forest University, Cardiology
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Wake Forest University, Endocrinology
mi
from
Winston-Salem, NC
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Wake Forest University, Endocrinology
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Portland VA Medical Center
mi
from
Portland, OR
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital
mi
from
Houston, TX
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Mcguire Va Medical Center
mi
from
Richmond, VA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Puget Sound VA Medical Center, Seattle Campus
mi
from
Seattle, WA
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Puget Sound VA Medical Center, Seattle Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated:  12/31/1969
Heart Health Institute
mi
from
Calgary,
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Status: Enrolling
Updated: 12/31/1969
Heart Health Institute
mi
from
Calgary,
Click here to add this to my saved trials
Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume
Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume
Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Andalusia, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Andalusia, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Athens, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Athens, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Huntsville, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Mobile, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Mobile, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Montgomery, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Muscle Shoals, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Ozark, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ozark, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Pell City, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Pell City, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Tuscumbia, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tuscumbia, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Flagstaff, AZ
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Glendale, AZ
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Scottsdale, AZ
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Sierra Vista, AZ
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Sierra Vista, AZ
Click here to add this to my saved trials